JPWO2023054292A1 - - Google Patents
Info
- Publication number
- JPWO2023054292A1 JPWO2023054292A1 JP2022565717A JP2022565717A JPWO2023054292A1 JP WO2023054292 A1 JPWO2023054292 A1 JP WO2023054292A1 JP 2022565717 A JP2022565717 A JP 2022565717A JP 2022565717 A JP2022565717 A JP 2022565717A JP WO2023054292 A1 JPWO2023054292 A1 JP WO2023054292A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021157929 | 2021-09-28 | ||
JP2021157929 | 2021-09-28 | ||
JP2021171725 | 2021-10-20 | ||
JP2021171725 | 2021-10-20 | ||
JP2022000723 | 2022-01-05 | ||
JP2022000723 | 2022-01-05 | ||
JP2022015035 | 2022-02-02 | ||
JP2022015035 | 2022-02-02 | ||
JP2022131590 | 2022-08-22 | ||
JP2022131590 | 2022-08-22 | ||
PCT/JP2022/035803 WO2023054292A1 (ja) | 2021-09-28 | 2022-09-27 | トリアジン誘導体を含有する医薬組成物 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP7236065B1 JP7236065B1 (ja) | 2023-03-09 |
JPWO2023054292A1 true JPWO2023054292A1 (ja) | 2023-04-06 |
JPWO2023054292A5 JPWO2023054292A5 (ja) | 2023-09-06 |
Family
ID=85476839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022565717A Active JP7236065B1 (ja) | 2021-09-28 | 2022-09-27 | トリアジン誘導体を含有する医薬組成物 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP7236065B1 (ja) |
KR (1) | KR20240082359A (ja) |
AU (1) | AU2022353486A1 (ja) |
CA (1) | CA3233206A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7273455B1 (ja) * | 2022-01-19 | 2023-05-15 | 塩野義製薬株式会社 | 新型コロナウイルス感染症治療用医薬 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1053230A1 (en) * | 1998-01-13 | 2000-11-22 | Scriptgen Pharmaceuticals, Inc. | Triazine antiviral compounds |
MX2011008362A (es) | 2009-02-13 | 2011-08-24 | Shionogi & Co | Derivado novedoso de triazina y composicion farmaceutica que comprende el mismo. |
CA2807947C (en) | 2010-08-10 | 2018-06-19 | Shionogi & Co., Ltd. | Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
WO2013089212A1 (ja) | 2011-12-15 | 2013-06-20 | 塩野義製薬株式会社 | 置換トリアジン誘導体およびそれらを含有する医薬組成物 |
TWI637949B (zh) | 2013-06-14 | 2018-10-11 | 塩野義製藥股份有限公司 | 胺基三衍生物及含有其等之醫藥組合物 |
JPWO2019087884A1 (ja) * | 2017-10-31 | 2020-11-19 | 富士フイルム株式会社 | 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー |
CN114641485A (zh) | 2020-04-05 | 2022-06-17 | 辉瑞大药厂 | 用于治疗covid-19的化合物和方法 |
US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
EP4282420A1 (en) * | 2021-01-20 | 2023-11-29 | National University Corporation Hokkaido University | Anti-viral agent |
WO2022212314A1 (en) * | 2021-03-29 | 2022-10-06 | Shireen Nature Company For General Trading, Ltd. | Willow extract and its use in treating coronavirus infection, inflammation, and associated medical conditions |
WO2022138988A1 (ja) * | 2021-04-14 | 2022-06-30 | 塩野義製薬株式会社 | ウイルス増殖阻害作用を有するトリアジン誘導体およびそれらを含有する医薬組成物 |
-
2022
- 2022-09-27 JP JP2022565717A patent/JP7236065B1/ja active Active
- 2022-09-27 CA CA3233206A patent/CA3233206A1/en active Pending
- 2022-09-27 KR KR1020247013026A patent/KR20240082359A/ko unknown
- 2022-09-27 AU AU2022353486A patent/AU2022353486A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP7236065B1 (ja) | 2023-03-09 |
AU2022353486A1 (en) | 2024-05-02 |
KR20240082359A (ko) | 2024-06-10 |
CA3233206A1 (en) | 2023-04-06 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221026 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221026 |
|
A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A801 Effective date: 20221026 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20221026 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221028 |
|
A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A80 Effective date: 20221028 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230214 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230214 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7236065 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |